Comparison Chart Eurofins Scientific SE

Stocks

ERF

FR0014000MR3

Biotechnology & Medical Research

Real-time Euronext Paris Other stock markets 10:37:30 21/07/2026 +03			5-day change	1st Jan Change
69.42 ^EUR	-2.36%		+0.55%	+11.19%

07-20	Eurofins Scientific SE agreed to acquire Life Sciences Testing Services Business in North America from Element Materials Technology Group Limited for an enterprise value of $400 million.	CI
07-20	Eurofins strengthens its North American footprint with an acquisition

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	EUROFINS SCIENTIFIC SE	Other Biotechnology & Medical Research	-2.36%	+0.55%	+11.19%	+12.67%	-30.74%	14.18B